MERCAPT mercaptopurine monohydrate 50 mg tablet bottle

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

mercaptopurine monohydrate, Quantity: 50 mg

Disponível em:

Aspen Pharmacare Australia Pty Ltd

DCI (Denominação Comum Internacional):

mercaptopurine monohydrate

Forma farmacêutica:

Tablet, uncoated

Composição:

Excipient Ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch

Via de administração:

Oral

Unidades em pacote:

25 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

INDICATIONS AS AT 5 March 2004: Treatment of leukemia. It is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. MERCAPT is also used in the treatment of chronic granulocytic leukaemia.

Resumo do produto:

Visual Identification: Pale yellow, round, biconvex tablets, marked PT above the line and 50 below the line on one side and plain on the other.; Container Type: Bottle; Container Material: Glass; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status de autorização:

Licence status A

Data de autorização:

2017-09-21